2/2 trans-ancestry genomic analysis of obsessive compulsive disorder
Active Cooperative Agreement Awarded Last action
- Award ID
- U01MH125062
- Recipient
-
Baylor College Of Medicine UEI FXKMA43NTV21
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,206,044
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date 88% complete
- Originally
- Funding
-
- $7,773,727.00 Federal
- $432,317.00 Non-federal
- Place of performance
- Houston, TX 77030, USA
Award details come from USAspending.gov.
Description
- Abstract
- In this study we seek to understand how genetic factors influence the risk of developing obsessive-compulsive disorder (OCD) in latin american individuals. OCD and related disorders are of major public health importance owing to their profound personal and societal costs. Little is known for certain about their etiology, and treatment, detection and prevention strategies are not optimal or directed by knowledge of pathophysiology. In other psychiatric disorders (e.g., schizophrenia, bipolar disorder, and autism), genomics has begun to deliver fundamental knowledge about genetic architecture, identify specific loci for biological follow-up and localize pathways altered in disease. We intend to realize these same advances for OCD by markedly increasing and diversifying the worldwide sample size for genomic analysis, in a first step toward elucidating the fundamental biology of this condition. Three overlapping areas will be investigated in this project. First, we will collect the world's largest ancestrally- diverse sample of OCD cases (n = 5,000 individuals from latin america). To do this in an efficient and cost- effective manner, we will take advantage of a network of OCD clinics we have established across latin america, in addition to clinics in the USA and web-based recruitment. The phenotypic data collected will include a detailed clinical characterization including comorbidities and OCD symptom dimensions. Second, we will genotype all 5,000 samples on the illumina global screening array (genotypes for >10,000 matched controls will be available). This will allow US to, in collaboration with the psychiatric genomics consortium, discover genomic loci harboring common variation associated with OCD. Third, we will fine-map genome-wide significant loci and calculate individual polygenic risk scores (PRS) as a measure of genetic liability to OCD. We expect the new inclusion of ancestrally diverse samples to improve our fine-mapping ability, to yield more accurate PRS in non-european samples and ultimately to reduce health disparities when OCD genomic findings are used clinically. Overall, this study will improve our understanding of the causal mechanisms implicated in OCD, with a view towards improving clinical outcomes and reducing chronicity and societal costs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $104,941 | |
| Amendment | $104,941 | |
| Amendment | -$104,941 | |
| Amendment | -$104,941 | |
| Amendment | $114,941 | |
| Amendment | $114,941 | |
| Amendment | $422,542 | |
| Amendment | $422,542 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $32,350 | |
| Amendment | $32,350 | |
| Amendment | $537,483 | |
| Amendment | $537,483 | |
| Amendment | $537,483 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $127,435 | |
| Amendment | $127,435 | |
| Amendment | $127,435 | |
| Amendment | $127,435 | |
| Amendment | $120,166 | |
| Amendment | $120,166 | |
| Amendment | $120,166 | |
| Amendment | $120,166 | |
| Amendment | $120,166 | |
| Amendment | $375,585 | |
| Amendment | $375,585 | |
| Amendment | $375,585 | |
| Amendment | $375,585 | |
| Amendment | $375,585 | |
| Amendment | $375,585 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $396,449 | |
| Amendment | $396,449 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 |
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Fundacao Faculdade De Medicina | $42,600 | |
| Fundacao Faculdade De Medicina | $352,955 |
Quick answers
Who received award U01MH125062?
U01MH125062 was awarded to Baylor College Of Medicine by National Institute of Mental Health (National Institutes of Health) on August 17, 2021.
How much is award U01MH125062 worth?
$8,206,044 has been obligated on U01MH125062: $7,773,727 in federal funding and $432,317 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award